Press Releases


Published on Wednesday, February 16, 2022

APhA congratulates Robert Califf, MD, on confirmation as FDA Commissioner

WASHINGTON, D.C.—The American Pharmacists Association (APhA) issued the following statement to congratulate Robert Califf, MD, on his confirmation to serve once again as commissioner of FDA. APhA looks forward to working with both Califf and the FDA to ensure the safety, efficacy, and security of medications for our nation’s pharmacy patients.

“Pharmacists must have trust and confidence in the medical products that their patients rely on,” said Ilisa Bernstein, PharmD, JD, FAPhA, APhA’s senior vice president for pharmacy practice and government affairs. “APhA welcomes the experience, dedication, and commitment to science and public health that Dr. Califf’s permanent leadership brings to the FDA during these challenging times.”

“As the medication experts, APhA has confidence that Dr. Califf’s focus on science-based decision-making will guide him at the helm at the FDA,” Bernstein continued.

APhA also thanks Janet Woodcock, MD, for her steadfast leadership as acting commissioner. APhA looks forward to continuing to work with her in her new role as principal deputy commissioner.”

About APhA
APhA is the only organization advancing the entire pharmacy profession. Our expert staff and strong volunteer leadership, including many experienced pharmacists, allow us to deliver vital leadership to help pharmacists, pharmaceutical scientists, student pharmacists, and pharmacy technicians find success and satisfaction in their work and advocate for changes that benefit them, their patients, and their communities. For more information, please visit

APhA's letter of support to the U.S. Senate Committee on Health, Education, Labor and Pensions 


Rate this article:
No rating
Comments (0)Number of views (1428)
Please login or register to post comments.